Tau Consortium: A collaborative program funding world-class research for neurodegenerative disease treatment.
Founded
2009
Location
Fort Worth, TX, US
Founded and managed by the Rainwater Charitable Foundation, the Tau Consortium is a collaborative research initiative focused on treating neurodegenerative diseases. Its core mission is to commission and support world-class research and drug discovery aimed at both primary tauopathies, such as progressive supranuclear palsy, and secondary tauopathies, including Alzheimer’s disease. By engaging talented researchers, the consortium seeks to advance scientific understanding and develop effective treatments for these debilitating conditions.
The Tau Consortium has attracted notable researchers and investors dedicated to combating neurodegenerative diseases. Its key achievements include significant advancements in understanding tau protein pathology and the development of potential therapeutic strategies. The consortium's impact is evident in its contributions to the scientific community and its role in fostering collaborative efforts to find cures for tau-related disorders.
